Profile
Jennifer Glennon worked as Head-Global Research & Development Business at LEO Pharma.
A from 2012 to 2015.
Prior to that, she was the Chief Financial Officer at Nordic Biotech Advisors ApS from 2008 to 2011.
From 2015 to 2018, she worked as Vice President-Finance & Operations at Evelo Biosciences, Inc. Ms. Glennon completed her undergraduate degree at INSEAD.
Former positions of Jennifer Glennon
| Companies | Position | End |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Chief Operating Officer | 01/11/2018 |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | 01/01/2015 |
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Director of Finance/CFO | 30/11/2011 |
Training of Jennifer Glennon
| INSEAD | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EVELO BIOSCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Finance |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
- Stock Market
- Insiders
- Jennifer Glennon
